Monthly price caps and more competition may be more impactful for patients than the slashing of insulin list prices
The three primary manufacturers of insulin in the United States have each announced major price cuts on their products, signaling a shift in notoriously expensive diabetes care:
Read more here: https://www.verywellhealth.com/american-cost-of-insulin-after-price-cuts-report-7483240